(Q46824045)

English

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

scientific article published on 30 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

0 references

Mariano Valdés Chávarri

5

object named as

Mariano Valdés

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

author name string

Pieter Cornelis Smits

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Sjoerd Hofma

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Mario Togni

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Nicolás Vázquez

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Vassilis Voudris

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Ton Slagboom

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Jean-Jaques Goy

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Andre Vuillomenet

9

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Antoni Serra

10

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Ramiro Trillo Nouche

11

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Peter den Heijer

12

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Martin van der Ent

13

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

language of work or name

0 references

publication date

30 January 2013

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

381

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

9867

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

651-660

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

First clinical comparison of Nobori -Biolimus A9 eluting stents with Cypher- Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stent thrombosis: has the firestorm been extinguished?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ s

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with revascularization procedures does matter: low volume means worse outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiogr

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961852-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)61852-2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/23374650

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46824045&oldid=2133728912"